The University of Chicago Header Logo

Connection

Rolf Barth to Hepatitis C

Back to Details
This is a "connection" page, showing publications Rolf Barth has written about Hepatitis C.
Rolf Barth
Connection Strength
0.675
Hepatitis C
  1. Safety of belatacept bridging immunosuppression in hepatitis C-positive liver transplant recipients with renal dysfunction. Transplantation. 2014 Jan 27; 97(2):133-7.
    View in: PubMed
    Score: 0.399
  2. The Impact of Treatment Delay on Hepatitis C Liver Transplant Outcomes. J Pharm Pract. 2023 Apr; 36(2):264-270.
    View in: PubMed
    Score: 0.167
  3. Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts. Transplantation. 2015 Jun; 99(6):1192-6.
    View in: PubMed
    Score: 0.109
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.